malR-Knockout Bacillus licheniformis for Bacitracin Yield

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for increasing Bacitracin yield in Bacillus licheniformis focus on amino acid supply rather than genetic modification, with limited understanding of which genes affect yield and effective genetic modification techniques.

Innovation Solution

A method for constructing a malR-knockout Bacillus licheniformis strain by PCR amplification, restriction enzyme digestion, and plasmid transformation to knockout the malR gene, a carbon metabolism transcription factor, resulting in a strain with increased Bacitracin production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If genetic modification methods are used to increase Bacitracin yield, then productivity is improved, but device complexity and manufacturing difficulty increase due to limited understanding of effective genetic modification techniques

Engineering Contradiction:
ImproveBacitracin yieldVSAvoidgenetic modification complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention extracts and removes the malR gene from the Bacillus licheniformis genome through targeted knockout. By specifically eliminating this single transcriptional regulator gene rather than attempting complex multi-gene modifications, the method simplifies the genetic engineering process while achieving significant Bacitracin yield improvement of over 23%.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the genetic parameter by knocking out the malR gene, which regulates carbon metabolism. This parameter change in the bacterial genome directly leads to improved Bacitracin production, demonstrating that modifying specific genetic parameters can enhance antibiotic yield without requiring complex modification systems.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If transcriptional regulators are modified to increase Bacitracin yield, then productivity is improved, but manufacturing precision is worsened due to lack of knowledge on which genes to target

Engineering Contradiction:
ImproveBacitracin yieldVSAvoidgene targeting precision
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention identifies and extracts the specific malR gene as the target for knockout. By focusing on this single transcriptional regulator rather than attempting to modify multiple unknown genes, the method achieves both high productivity improvement and precise genetic modification, eliminating the uncertainty about which genes to target.

Inventive Principle:
Principle #2Taking out (Extraction)

3Productivity

If amino acid supply is increased to boost Bacitracin production, then productivity is improved, but loss of substance increases due to resource allocation to precursor synthesis

Engineering Contradiction:
ImproveBacitracin yieldVSAvoidamino acid consumption
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The invention converts the harmful effect of amino acid depletion into a benefit by knocking out the malR gene, which regulates carbon metabolism. This genetic modification redirects metabolic flux toward Bacitracin synthesis, improving yield without requiring additional amino acid supplementation and actually reducing the loss of precursor substances.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The malR-knockout strain achieves a yield increase of over 23% in Bacitracin compared to the wild-type strain, demonstrating the effectiveness of genetic modification in enhancing antibiotic production.

Implementation Method 1

using genomic DNA of Bacillus licheniformis DW2 as a template, obtaining an upstream homology arm of the malR gene and a downstream homology arm of the malR gene by PCR (polymerase chain reaction) amplification

Methodology Applied
Scientific EffectPCR (polymerase chain reaction):

Implementation Method 2

performing double digests of the target gene segment by XbaI and BamHI restriction enzymes to obtain a digested gene segment

Methodology Applied
Scientific EffectRestriction enzyme digestion: Enzyme

Implementation Method 3

ligating the digested gene segment obtained in step (3) and the linear plasmid segment obtained in step (4) by DNA ligase to obtain a knockout plasmid T2(2)-ΔmalR

Methodology Applied
Scientific EffectDNA ligation: Enzyme

Implementation Method 4

transforming the knockout plasmid T2(2)-ΔmalR into Bacillus licheniformis DW2, and screening to obtain a positive transformant using kanacillin as a screening marker

Methodology Applied
Scientific EffectAntibiotic selection:

Implementation Method 5

after transferring and culturing the positive transformant for several times at 45° C., performing colony PCR to obtain positive single crossover binder strains

Methodology Applied
Scientific EffectHeat-induced recombination: Heat Treatment

Data Source

PatentUS11111516B2malR-knockout <i>Bacillus licheniformis </i>strain, construction method and use
Publication Date: 2021.09.07 LIFECOME BIOCHEM
  • US11111516B2 patent drawing
  • US11111516B2 patent drawing
  • US11111516B2 patent drawing

AI summary

Provided are malR-knockout Bacillus licheniformis strain, a construction method and a use. Using a genetic engineering method, gene, namely, the malR gene, which is in charge of conducting the transcription of the carbon metabolism transcription factor MalR, in the genome of Bacillus licheniformis DW2 is knocked out, thereby successfully obtaining Bacillus licheniformis DW2ΔmalR, from which the malR gene has been deleted. In comparison with Bacillus licheniformis DW2, the strain obtained by the construction can improve the Bacitracin yield in a fermentation broth during Bacitracin fermentation by at least 23%.